blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2161028

EP2161028 - Food product comprising dipeptides having antihypertensive properties. [Right-click to bookmark this link]
Former [2010/10]Composition comprising peptides
[2010/26]
StatusNo opposition filed within time limit
Status updated on  11.11.2011
Database last updated on 05.10.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU
published on 06.11.2013  [2013/45]
Applicant(s)For:AT  BE  BG  CH  CZ  DE  DK  EE  ES  FI  FR  GR  HR  HU  IS  IT  LI  LT  LU  LV  MC  NL  NO  PL  PT  RO  SE  SI  SK  TR 
Unilever N.V.
Weena 455
3013 AL Rotterdam / NL
For:CY  GB  IE  MT 
Unilever PLC
Unilever House
100 Victoria Embankment
London
EC4Y 0DY / GB
[N/P]
Former [2010/10]For:AT  BE  BG  CH  CZ  DE  DK  EE  ES  FI  FR  GR  HR  HU  IS  IT  LI  LT  LU  LV  MC  NL  NO  PL  PT  RO  SE  SI  SK  TR 
Unilever N.V.
Weena 455
3013 AL Rotterdam / NL
For:CY  GB  IE  MT 
Unilever PLC
Unilever House 100 Victoria Embankment London
EC4Y 0DY / GB
Inventor(s)01 / van Buren, Leendert
c/o Unilever R&D Vlaardingen B.V. Olivier van Noortlan 120
3133 AT Vlaardingen / NL
02 / Foltz, Martin
c/o Unilever R&D Vlaardingen B.V. Olivier van Noortlan 120
3133 AT Vlaardingen / NL
03 / Ramcharan, Jane Rita
c/o Unilever R&D Vlaardingen B.V. Olivier van Noortlan 120
3133 AT Vlaardingen / NL
 [2010/10]
Representative(s)Corsten, Michael Allan, et al
Unilever N.V.
Unilever Patent Group
Bronland 14
6708 WH Wageningen / NL
[N/P]
Former [2010/10]Corsten, Michael Allan, et al
Unilever Patent Group Olivier van Noortlaan 120
3133 AT Vlaardingen / NL
Application number, filing date08163907.209.09.2008
[2010/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2161028
Date:10.03.2010
Language:EN
[2010/10]
Type: B1 Patent specification 
No.:EP2161028
Date:05.01.2011
Language:EN
[2011/01]
Search report(s)(Supplementary) European search report - dispatched on:EP27.02.2009
ClassificationIPC:A61K38/05, A61P9/12, A23L1/305
[2010/28]
CPC:
A61K38/05 (EP); A23C19/0921 (EP); A23C9/1322 (EP);
A23C9/1526 (EP); A23D7/0056 (EP); A23L2/02 (EP);
A23L2/52 (EP); A23L33/18 (EP); A61P9/12 (EP);
A23V2002/00 (EP) (-)
C-Set:
A23V2002/00, A23V2200/326, A23V2250/06 (EP)
Former IPC [2010/10]A61K38/05, A61P9/12
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/10]
TitleGerman:Nahrungsmittel enthaltend Dipeptide mit blutdrucksenkenden Eigenschaften.[2010/26]
English:Food product comprising dipeptides having antihypertensive properties.[2010/26]
French:Aliment contenant dipeptides des propriétés antihypertensives.[2010/26]
Former [2010/10]Zusammensetzung, die Peptide umfasst
Former [2010/10]Composition comprising peptides
Former [2010/10]Composition comprenant des peptides
Examination procedure23.06.2009Examination requested  [2010/10]
22.07.2009Despatch of a communication from the examining division (Time limit: M06)
07.01.2010Reply to a communication from the examining division
03.08.2010Communication of intention to grant the patent
22.10.2010Fee for grant paid
22.10.2010Fee for publishing/printing paid
Opposition(s)06.10.2011No opposition filed within time limit [2011/50]
Fees paidRenewal fee
27.09.2010Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
HR05.01.2011
HU05.01.2011
IT05.01.2011
LT05.01.2011
LV05.01.2011
MT05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
TR05.01.2011
BG05.04.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
IE09.09.2011
LU09.09.2011
MC30.09.2011
[2013/45]
Former [2013/44]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
HR05.01.2011
IT05.01.2011
LT05.01.2011
LV05.01.2011
MT05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
TR05.01.2011
BG05.04.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
IE09.09.2011
LU09.09.2011
MC30.09.2011
Former [2013/25]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
HR05.01.2011
IT05.01.2011
LT05.01.2011
LV05.01.2011
MT05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
BG05.04.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
IE09.09.2011
LU09.09.2011
MC30.09.2011
Former [2013/14]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
HR05.01.2011
IT05.01.2011
LT05.01.2011
LV05.01.2011
MT05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
BG05.04.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
IE09.09.2011
MC30.09.2011
Former [2012/35]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
HR05.01.2011
IT05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
BG05.04.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
IE09.09.2011
MC30.09.2011
Former [2012/20]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
HR05.01.2011
IT05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
BG05.04.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
MC30.09.2011
Former [2012/03]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
HR05.01.2011
IT05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
BG05.04.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/49]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
HR05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
BG05.04.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/47]AT05.01.2011
BE05.01.2011
CY05.01.2011
DK05.01.2011
EE05.01.2011
HR05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
SE05.01.2011
SI05.01.2011
BG05.04.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/38]AT05.01.2011
BE05.01.2011
CY05.01.2011
HR05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
SE05.01.2011
SI05.01.2011
BG05.04.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/37]BE05.01.2011
CY05.01.2011
HR05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
SE05.01.2011
SI05.01.2011
BG05.04.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/36]HR05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
SE05.01.2011
SI05.01.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/35]HR05.01.2011
LT05.01.2011
LV05.01.2011
SE05.01.2011
SI05.01.2011
NO05.04.2011
ES16.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/34]LT05.01.2011
SE05.01.2011
SI05.01.2011
NO05.04.2011
ES16.04.2011
PT05.05.2011
Documents cited:Search[A]EP0821968  (CALPIS FOOD IND CO LTD [JP]) [A] 1-6 * abstract * * page 2, line 40 - line 48 * * page 3, line 33 - line 49 *;
 [A]US6060452  (GREEN LAWRENCE R [US], et al) [A] 1-6 * abstract * * column 1, line 15 - line 21 * * column 5, line 45 - line 50 ** column 7, line 14 - line 15 *;
 [A]WO2006084560  (UNILEVER NV [NL], et al) [A] 1-6 * abstract * * page 3, line 25 - line 28 * * page 10, line 21 - line 29 *;
 [A]EP1726659  (HANSENS LAB [DK]) [A] 1-6 * abstract * * columns 4,6,9 * * columns 16,27 - column 31 *
by applicant   - GERSTEIN ET AL., THE LANCET, (2000), vol. 355, pages 253 - 259
    - HATA, Y ET AL., AMERICAN JOURNAL OF CLINICAL NUTRITION, (1996), vol. 64, pages 767 - 771
    - VAN PLATERINK CJ ET AL., "Quantification of ACE inhibiting peptides in human plasma using high performance liquid chromatography-mass spectrometry", J CHROMATOGR B ANALYT TECHNOL BIOMED LIFE SCI, (2006), vol. 830, doi:doi:10.1016/j.jchromb.2005.10.036, pages 151 - 157, XP025122364

DOI:   http://dx.doi.org/10.1016/j.jchromb.2005.10.036
    - VAN PLATERINK CJ; JANSSEN HG; HAVERKAMP J, "Development of an at-line method for the identification of angiotensin-I inhibiting peptides in protein hydrolysates", J CHROMATOGR B ANALYT TECHNOL BIOMED LIFE SCI, (2007), vol. 846, no. 1-2, doi:doi:10.1016/j.jchromb.2006.08.052, pages 147 - 154, XP005862585

DOI:   http://dx.doi.org/10.1016/j.jchromb.2006.08.052
    - HELLBERG S ET AL., "Peptide Quantitative Structure-Activity-Relationships, A Multivariate Approach", J MED CHEM, (1987), vol. 30, doi:doi:10.1021/jm00390a003, pages 1126 - 1135, XP000877494

DOI:   http://dx.doi.org/10.1021/jm00390a003
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.